Km. Gressani et al., Strain-dependent lung tumor formation in mice transplacentally exposed to 3-methylcholanthrene and post-natally exposed to butylated hydroxytoluene, CARCINOGENE, 20(11), 1999, pp. 2159-2165
The carcinogenic effects of in utero exposure to 3-methylcholanthrene (MC)
have been demonstrated in the tumor-resistant C57BL/6 (B6) and DBA (D2) str
ains of mice, In this study, we determined the effects of in utero exposure
to MC in BALB/c mice, a strain which demonstrates greater susceptibility t
o lung tumor induction, and compared our findings with those previously fou
nd in [D2 x B6D2F(1)]F-2 mice. In addition, we assessed the molecular patho
genesis of the chemically induced tumors and examined the effects of the pu
tative lung tumor promoter butylated hydroxytoluene (BHT) in BALB/c mice. B
ALB/c mice were treated on day 17 of gestation with 5, 15 or 45 mg/kg MC an
d 6 weeks after birth with BHT for 6 consecutive weeks. Mice were killed at
6 months of age. Ki-ras, p16(Ink4a) and p19(ARF) gene loci were amplified
from paraffin-embedded lung tumor tissue and screened for the presence of p
oint mutations via allele-specific oligonucleotide hybridization and single
strand conformation polymorphism (SSCP) analyses. Ki-ras point mutations w
ere found in 56% (20/36) of BALB/c lung tumors, with 33% (2/6) of the hyper
plasias, 58% (10/19) of the adenomas and 73% (8/11) of the carcinomas exhib
iting point mutations at this gene locus, Similar incidences of Ki-ras muta
tions were previously found following transplacental exposure of [D2 X B6D2
F(1)]F-2 mice to MC and treatment of adult A/J mice with urethane, Interest
ingly, a strain-dependent difference was observed in the mutational spectru
m, Sixty-two and 38% of the lung lesions in BALB/c mice exhibited G-->C and
G-->T transversions, respectively, in contrast to the 13 and 84% incidence
s previously observed in [D2 X B6D2F(1)]F-2 mice. SSCP analysis of the tumo
r suppressor gene p16(Ink4a) showed a 6% incidence of point mutations, cons
istent with that found in [D2 x B6D2F(1)]F-2 mice. No mutations were found
in exon 1 beta of the p19(ARF) gene of either strain. BHT, a lung tumor pro
moter in adult mice, had no statistically significant effects on either tum
or incidence, tumor multiplicity or the mutational spectrum produced in the
Ki-ms gene by in utero MC treatment. However, though not significant, ther
e was an observable trend in increased tumor multiplicity in mice co-treate
d with BHT, These data demonstrate the transplacental carcinogenic effect o
f MC in BALB/c mice and show that mutagenic damage to Ki-ras is a critical
early event mediating murine lung tumorigenesis in both the tumor-sensitive
and tumor-resistant strains. Unlike what occurs when adult BALB/c mice are
treated with MC, BHT does not appear to significantly promote the formatio
n of lung tumors following transplacental exposure to MC, possibly due to t
he rapid growth and cell proliferation in the developing organism. Strain-d
ependent differences in the Ki-ms mutational spectrum may be associated wit
h their differential susceptibility to lung tumor initiation.